When should Redotil (racecadotril) be administered for acute watery diarrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

When to Give Redotil (Racecadotril) for Loose Stools

Administer racecadotril as an adjunct to oral rehydration solution (ORS) in children aged 3 months to 5 years with acute watery diarrhea, but only after ensuring adequate hydration is initiated first. The drug should be given at 1.5 mg/kg orally every 8 hours, starting as soon as the diagnosis of acute watery diarrhea is made and rehydration therapy has begun 1, 2.

Key Timing Considerations

Start racecadotril immediately upon presentation with acute watery diarrhea, but never as a substitute for fluid and electrolyte therapy 3. The IDSA guidelines explicitly state that ancillary treatments can be considered once the patient is adequately hydrated, though they note racecadotril reduces stool volume 3.

Clinical Algorithm for Administration:

  1. First priority: Assess hydration status and initiate ORS or IV fluids if severely dehydrated
  2. Second step: Once rehydration is underway (not necessarily complete), add racecadotril
  3. Continue: Give racecadotril every 8 hours until diarrhea resolves
  4. Duration: Typically 28-72 hours based on clinical trials 1

Evidence Quality and Nuances

The evidence for racecadotril presents a mixed picture that requires careful interpretation:

Supportive evidence: Early studies from 2000-2001 showed racecadotril reduced 48-hour stool output by 46% and shortened diarrhea duration to 28 hours versus 72 hours with placebo 1, 2. These were well-designed trials in hospitalized children.

Contradictory evidence: A 2019 Cochrane review found insufficient evidence to support routine use, concluding racecadotril "has little benefit" 4. More critically, a 2026 systematic review using rigorous methodology (REB method) found "absence of evidence" for efficacy, as only one low-risk-of-bias trial existed and showed neither statistically nor clinically significant effects 5.

Critical Pitfall to Avoid

Do not use racecadotril in place of rehydration therapy - this is the most dangerous error. The drug only addresses secretory diarrhea; it does not replace lost fluids and electrolytes 3, 6.

Contraindications and When NOT to Give

Avoid racecadotril in:

  • Bloody diarrhea or suspected inflammatory diarrhea (risk of toxic megacolon)
  • Fever with diarrhea (suggests invasive pathogen)
  • Children under 3 months of age (insufficient safety data)
  • Severe dehydration before rehydration is initiated

Practical Dosing

  • Dose: 1.5 mg/kg every 8 hours
  • Route: Oral
  • Duration: Until diarrhea resolves (typically 1-3 days)
  • Safety profile: Well-tolerated with only mild, transient adverse effects reported 1, 6

Real-World Clinical Decision

Given the conflicting evidence, with the most recent high-quality systematic review 5 showing no clear benefit, racecadotril should be considered optional rather than essential. The 2017 IDSA guidelines note it reduces stool volume but is not available in North America, suggesting limited enthusiasm for its routine use 3.

In resource-limited settings where hospitalization costs are significant, racecadotril may offer cost savings by reducing hospital stays 7, which could justify its use despite marginal clinical benefit. However, in well-resourced settings, ORS alone remains the evidence-based standard, with racecadotril offering minimal additional benefit beyond what the most recent rigorous analysis supports.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.